Stage IV Rectal Cancer (DBCOND0028778)

Identifiers

Synonyms
Rectal cancer stage IV / Rectal cancer metastatic / Carcinoma of rectum stage IV / Carcinoma rectum stage IV / Rectal carcinoma stage IV / Rectal cancer Dukes D

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05830890
Sentinel Lymph Node Biopsy in Rectal CancerdiagnosticNot Availablenot_yet_recruiting
NCT01037790
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancertreatment2completed
NCT00551421
Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancertreatment1 / 2completed
NCT01285102
Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancertreatment1terminated
NCT01934179
Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing ChemotherapyNo drug interventionsNot AvailableNot Availableterminated
NCT01116687
RO4929097 in Treating Patients With Metastatic Colorectal Cancertreatment2completed
NCT00088933
Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancertreatment1terminated
NCT00407654
VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancertreatment2completed
NCT00504153
Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancertreatment2completed
NCT00138177
Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumorstreatment1completed
NCT01105377
Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancertreatment2completed
NCT01233505
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumorstreatment1terminated
NCT00397878
AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancertreatment2terminated
NCT00052585
Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancertreatment2terminated
NCT00025337
Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treatedtreatment3completed
NCT04267575
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor SitesNo drug interventionstreatmentNot Availableunknown_status
NCT00005818
SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancertreatment1 / 2completed
NCT00100841
Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancertreatment2completed
NCT00026234
Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Livertreatment2completed
NCT00028496
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancertreatment1completed
NCT00070265
Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancertreatment2terminated
NCT01158274
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumorstreatment1completed
NCT00826540
Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancertreatment2completed
NCT01814501
Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumabtreatment2unknown_status
NCT00134069
Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancertreatment1completed
NCT00032110
Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancertreatment2completed
NCT00031681
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)treatment1completed
NCT03154190
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerNo drug interventionshealth_services_researchNot Availableunknown_status
NCT01191684
Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancertreatment1completed
NCT00397384
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancertreatment1completed
NCT00835679
Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgerybasic_science0terminated
NCT00023933
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancertreatment1completed
NCT04046445
Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancertreatment1active_not_recruiting
NCT00030498
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunctiontreatment1completed
NCT01652196
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancertreatment2unknown_status
NCT00070122
Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancertreatment3terminated
NCT01205022
Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancertreatment1completed
NCT04044430
Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancertreatment1terminated
NCT01198548
High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancertreatment2terminated
NCT00101348
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancertreatment1 / 2completed
NCT01294826
Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancertreatment1completed
NCT00942266
Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatmenttreatment2completed
NCT01238965
Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapytreatment1terminated
NCT00004074
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neutreatment1completed
NCT00003873
Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancertreatment3completed
NCT00019760
Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Livertreatment2completed
NCT00087191
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerdiagnosticNot Availableterminated
NCT00041340
Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancertreatment2completed
NCT00645710
Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgerytreatment1 / 2completed